| 11.805 0.125 (1.07%) | 08-14 15:17 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 14.36 | 1-year : | 15.78 |
| Resists | First : | 12.3 | Second : | 13.51 |
| Pivot price | 11.65  |
|||
| Supports | First : | 10.34 | Second : | 8.6 |
| MAs | MA(5) : | 12.04  |
MA(20) : | 11.59 |
| MA(100) : | 0 | MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 41 |
D(3) : | 53.3 |
| RSI | RSI(14): 47.6 |
|||
| 52-week | High : | 15.28 | Low : | 10.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ MOBI ] has closed below upper band by 47.3%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 11.77 - 11.83 | 11.83 - 11.89 |
| Low: | 11.09 - 11.17 | 11.17 - 11.25 |
| Close: | 11.55 - 11.68 | 11.68 - 11.8 |
Mobia Medical, Inc. functions as a commercial-level medical device enterprise, concentrating on developing therapeutic solutions for individuals recovering from strokes who experience motor impairments. The company was established on March 5, 2007, by its founders Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, and it maintains its corporate headquarters in Austin, Texas.
Thu, 13 Aug 2026
Mobia Medical (MOBI) investors report up to 11.6% ownership in Schedule 13G - Stock Titan
Wed, 12 Aug 2026
Mobia Medical, Inc. - Common Stock (MOBI) Stock Price, News, Quote & History - FinancialContent
Tue, 11 Aug 2026
Mobia Medical (MOBI) doubles revenue as IPO cash lifts balance sheet - Stock Titan
Tue, 11 Aug 2026
Mobia Medical (MOBI) doubles Q2 revenue and issues strong 2026 outlook - Stock Titan
Tue, 11 Aug 2026
Mobia Medical Reports About $134M IPO Proceeds, $177M Cash - Stock Titan
Tue, 11 Aug 2026
Mobia Medical, Inc. - Common Stock (Nasdaq:MOBI) Stock Quote - The Chronicle-Journal
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Specialties
|
|
| Shares Out | 33 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 7.1 (%) |
| Held by Institutions | 30.8 (%) |
| Shares Short | 422 (K) |
| Shares Short P.Month | 828 (K) |
| EPS | -1.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -167.2 |
| Profit Margin | -139.4 % |
| Operating Margin | -140.3 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 113.3 % |
| Gross Profit (p.s.) | 0.94 |
| Sales Per Share | 1.15 |
| EBITDA (p.s.) | -1.59 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -54 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -7.25 |
| PEG Ratio | 0 |
| Price to Book value | -0.08 |
| Price to Sales | 10.14 |
| Price to Cash Flow | -7.27 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|